Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Aug 23, 2024, 14:21 |
Drugs
Stephen V Liu: How do we select the optimal regimen for EGFR NSCLC?
Stephen V Liu shared on X: "With FLAURA (osimertinib alone), FLAURA2 (osimertinib with chemotherapy), and…
Aug 23, 2024, 06:30 |
Drugs
Taha Al-Juhaishi: Treatment of AML in the community setting
Taha Al-Juhaishi, Associate Director of Hematopoietic Stem Cell Transplantation and Cell Therapy at OU Health…
Aug 22, 2024, 14:52 |
Blog
New Lung Cancer Considered Episode with Narjust Florez and Julia Rotow
Florez Lab shared a post on X: "FDA approved lazertinib + amivantamab for first-line treatment…
Aug 22, 2024, 13:46 |
Insight
Hagop Kantarjian: The latest advancements and progress in treating AML
Hagop Kantarjian shared a post on X: “Recording now available: The latest advancements and progress…
Aug 21, 2024, 17:08 |
Insight
What oncologists say about the new approval of Lazertinib and amivantamab for advanced NSCLC
On August 19, 2024, the FDA approved a new combination therapy for advanced non-small cell…
Aug 21, 2024, 16:40 |
Insight
Jeff Allen: How Can Real-World Data Be Used To Measure Treatment Response Rates?
Jeff Allen, President and CEO of Friends of Cancer Research, shared a post on LinkedIn:…
Aug 21, 2024, 14:43 |
Blog
Science Saturday of anti-LAG-3 and anti-PD1 for advance melanoma with Patrick Hwu
Patrick Hwu shared a post on X: "The combination of anti-LAG-3 and anti-PD1 antibodies is US…
Aug 21, 2024, 14:03 |
Blog
$3 million research grant to Dana-Farber Cancer Institute and UT Health San Antonio to study BRCA therapy
Dana-Farber Cancer Institute shared on LinkedIn: "Scientists at Dana-Farber's Center for BRCA and Related Genes in…
Aug 21, 2024, 13:57 |
Blog
AACR - Broadening eligibility criteria for cancer clinical trials may better demonstrate how a drug will affect a real-world population
American Association for Cancer Research shared on LinkedIn: "Broadening eligibility criteria for cancer clinical trials allows…
Aug 20, 2024, 12:39 |
Insight
Patrick Hwu: How is the combination of anti-LAG-3 and anti-PD1 working mechanistically?
Patrick Hwu shared on X: “Science Sunday! The combination of anti-LAG-3 and anti-PD1 antibodies is…
35
36
37
38
39
All:
946
Posts:
361 - 370
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube